Transcriptional diversity and bioenergetic shift in human breast cancer metastasis revealed by single-cell RNA sequencing.

Journal Article

Although metastasis remains the cause of most cancer-related mortality, mechanisms governing seeding in distal tissues are poorly understood. Here, we establish a robust method for the identification of global transcriptomic changes in rare metastatic cells during seeding using single-cell RNA sequencing and patient-derived-xenograft models of breast cancer. We find that both primary tumours and micrometastases display transcriptional heterogeneity but micrometastases harbour a distinct transcriptome program conserved across patient-derived-xenograft models that is highly predictive of poor survival of patients. Pathway analysis revealed mitochondrial oxidative phosphorylation as the top pathway upregulated in micrometastases, in contrast to higher levels of glycolytic enzymes in primary tumour cells, which we corroborated by flow cytometric and metabolomic analyses. Pharmacological inhibition of oxidative phosphorylation dramatically attenuated metastatic seeding in the lungs, which demonstrates the functional importance of oxidative phosphorylation in metastasis and highlights its potential as a therapeutic target to prevent metastatic spread in patients with breast cancer.

Full Text

Duke Authors

Cited Authors

  • Davis, RT; Blake, K; Ma, D; Gabra, MBI; Hernandez, GA; Phung, AT; Yang, Y; Maurer, D; Lefebvre, AEYT; Alshetaiwi, H; Xiao, Z; Liu, J; Locasale, JW; Digman, MA; Mjolsness, E; Kong, M; Werb, Z; Lawson, DA

Published Date

  • March 2020

Published In

Volume / Issue

  • 22 / 3

Start / End Page

  • 310 - 320

PubMed ID

  • 32144411

Pubmed Central ID

  • 32144411

Electronic International Standard Serial Number (EISSN)

  • 1476-4679

Digital Object Identifier (DOI)

  • 10.1038/s41556-020-0477-0

Language

  • eng

Conference Location

  • England